济川药业：2025年前三季度净利润约10.22亿元

Group 1 - The core viewpoint of the article highlights that Jichuan Pharmaceutical (SH 600566) reported a significant decline in its third-quarter performance for 2025, with revenue decreasing by 32.27% year-on-year to approximately 3.932 billion yuan and net profit attributable to shareholders dropping by 46.27% to about 1.022 billion yuan [1][1][1] - As of the report, Jichuan Pharmaceutical has a market capitalization of 22.7 billion yuan [1][1][1]